Select Committee on Science and Technology Minutes of Evidence


Examination of Witnesses (Questions 60-79)

MR PATRICK MCDONALD, MR STEVE COLDRICK, MR CHRIS WELLS, DR PETER WRIGHT AND MS ANNE KIRKHAM

22 NOVEMBER 2006

  Q60  Chairman: Because it makes a difference.

  Mr McDonald: Volunteers for the scheme will get extra training at Manchester University who are running the overall core scheme for us.

  Q61  Chairman: Right, and how can you ensure that workers have access to occupational health services and occupational health physicians across the board, or are you now going to be relying on GPs who you are upskilling, which raises the question, what about other members of the workforce and how adequate is their access to advice?

  Mr McDonald: I think there is a general issue here where, certainly compared to other countries in Europe, access to occupational health advice is not as extensive. It is an issue that we need to consider, particularly in the context of our EMAS statutory duties.

  Q62  Lord Taverne: To follow up, on the information about those suffering from allergic conditions do you have any information about people whose genes may predispose them towards particular allergies like occupational asthma?

  Mr McDonald: Certainly there is a genetic component to allergies, things like hayfever and asthma do tend to run in families, but I do not think the evidence base available to us is wide enough to be able to tell specifically whether a particular genotype is responsible for allergic reactions.

  Q63  Baroness Platt of Writtle: What action is the HSE taking to prevent individuals from developing occupational allergic diseases? My mind flies to hairdressers because there is no doubt about it there is a certain amount of connection there, is there not?

  Mr Coldrick: In fact, yesterday on the specifics of hairdressers we launched the first National Hairdressers' Day, which was aimed specifically at dermatitis which, as we know, includes irritant contact dermatitis and allergic dermatitis, and that is one of our major target audiences in respect of skin disease which includes the allergic response. We have put together, if you like, an alliance of the people who supply the materials, the people who actually work with the hairdressers themselves, the trainers, and also looking at the local authorities who enforce. What we have learned in preparation for this campaign is that it is not straightforward. If I give you a specific example: some hairdressers feel that it is part of the job to have dermatitis and in some cases asthma. In fact, we had an e-mail from somebody who had been doing it for 34 years saying, "Stop whingeing and just get on with it and accept it," so there is an attitude problem. The second problem that we have is that when it comes to taking what are very sensible and simple precautions for protecting against allergic skin disease, dermatitis, hairdressers and salon owners shy away from that because they believe that the customers will not like hairdressers to wear, non-latex disposable gloves. So this campaign has been about dispelling some of the myths, and to get an attitude change, not only amongst the salon owners, not only amongst the hairdressers, but also amongst the clients, and that is the whole thrust of the campaign of which the Hairdressers' Day is a part. The campaign goes up to 20 December, but we are continuing because when you are talking about behaviour and attitudinal change we measure that in years rather than weeks.

  Q64  Baroness Platt of Writtle: What proportion of employers comply with legislation to provide a safe workplace for allergy sufferers and what procedures are in place to deal with employers who do not comply?

  Mr Coldrick: It is very difficult to answer the first question because within that there is a presumption that we know everything about everybody and that also there is a turnover of business from year to year, so there are businesses which are in business now which we and others do not know about, so it is very difficult to answer that question. What we do have, though, is a targeted approach. In the context of hairdressers, if I may stay with that, we have got a suite of approaches. First of all, we are trying to raise awareness and get people to understood causation and be committed, because it is just commonsense. Part of that is for the local authority environmental health officers (who are the regulators in hairdressing of health and safety matters) who as part of the disease reduction programme are visiting about 20,000 hairdressers over the coming year. Initially they will be taking the bag of materials which will demonstrate the use of gloves and moisturising cream, which is an essential component, but later in the programme we will be turning to enforcement. We want to give everybody the chance first to see the light before those who will not then need to feel the heat.

  Q65  Lord Broers: According to your evidence The Health and Occupational Reporting Network have reported a decrease in new cases of occupational asthma and work-related contact dermatitis in recent years. How robust are these data?

  Mr McDonald: As you will gather from the answer to the first question I was asked, there is some variability in this data and trying to find the numbers from the generality of common, multi-causal illnesses is a real challenge for us. What we do is collect information from a fairly broad range of sources and carry out a semi-quantitative integration, which is a rather fancy way of saying it is a well-informed judgment, and we use the important lead source for each of those data and then use other sources to guide our interpretation. Because it rests so much on judgment, we have been very keen to make sure that this work is peer reviewed, so we had a workshop at the beginning of the revitalising health and safety statistics which started in 2000 to test the robustness of our approach. We subsequently then discussed the approach with the Government's Statistical Service Methodology Committee and then there has been further external peer review as we have produced the figures. So our judgments on progress are published, along with our reasons for those numbers, as is the external peer review of what we are doing. What is important to us are trends rather than absolute numbers in what we do as an Executive. It is consistency over time which is the key criterion for us, for our robustness, and, as you say, THOR is the lead source for occupational asthma and contact dermatitis. We have asked Manchester University to do some further research and statistical modelling on these figures. The data are not perfect but they are certainly robust enough to support the general statements that we make about health and safety. Again, we are trying to look at this on a wider basis so we have a programme of evaluation that actually looks at the impact of our various interventions and assessing changes in good practice and changes in behaviour in our target groups. That way we hope to have a much more beneficial impact on the prevention of occupational asthma and contact dermatitis.

  Q66  Lord Broers: The difficulty with trends is that it does not help us with international comparisons necessarily, does it, as we discussed with the previous witnesses, and you say the differences in data collection procedures make international comparisons of work-related allergy prevalence problematic, so what do you plan to do about it?

  Mr McDonald: We are part of two EU working groups—the European Statistics of Accidents at Work and the European Occupational Disease Statistics—trying to standardise the position for work-related illness and injury. It is hugely challenging because we have all got very different systems of collecting statistics and we have very, very different cultural norms in terms of what is reported in workplace health. Whilst I welcome having established working groups, I do not think they are going to come to any useful conclusions any time quickly.

  Q67  Lord Colwyn: So are you assuming that everybody who has contact dermatitis or asthma always goes to see a doctor?

  Mr McDonald: It is a population-based survey. There is a real problem with these multi-causal illnesses and when somebody presents to the GP, the GP is not necessarily going to think of occupational health as the first cause, so that is why we rely on the self-reported survey which would have a tendency to over-report but at least gives us some confidence that we are picking up a reasonable indicator of the prevalence of illness.

  Q68  Lord Broers: You have set yourself a target of reducing occupational asthma and allergic contact dermatitis by 10 per cent by 2008 from a 2004 baseline. What practical measures are you implementing to meet that target?

  Mr Coldrick: That falls to the Disease Reduction Programme. What we have within that programme relevant to this inquiry are two projects, the respiratory disease project and the skin disease project, and we are targeting particular populations with the highest incidence. Just as I referred earlier to hairdressers, which is one of our target audiences, we are seeking to lead by working in partnership with all key stakeholders and influencers, including role models, ie in the case of hairdressing, to actually raise the level of awareness, get the understanding, gain the commitment, and achieve the behaviour change, and that is what the project is actually focused on. So it is a multi-stranded approach. It will be going through supply chain pressure, where possible, through trades unions' support, where that is relevant, education, to catch the people as they enter the particular target sector, to make them aware as to what the right thing is to do, and then also to raise awareness by those already in that particular target sector, to get them to understand what they need to do and why they need to do it, and in most cases why it is relatively simple; it needs an attitudinal change. Finally, of course there is always the regulatory enforcement role. It is what you might describe as a best mix approach to those particular sectors.

  Q69  Lord Colwyn: Do you have figures for the current level of industrial injuries disablement benefit being paid to employees from allergic disease and what sort of shape is the graph; is it rising rapidly? Could I also ask you at what stage is the employee labelled as having an allergic disease?

  Dr Wright: The first part of that answer is the industrial injuries scheme essentially starts payments if disability or disablement is present on the 91st day, so the first 90 days are not covered at all. Then after that the level of payment will depend on the degree of disablement, and in most cases of people with allergic disease that is likely to be relatively low. You have heard earlier about the possibility of more severe disability through complicating asthma, for example, and there the permanent disablement figure will be rather higher. In general terms, given the fluctuating nature of the disease, the levels of payment are likely to be quite low. The standard for an 18-year-old and over at the moment who is 100 per cent disabled—that is really severely disabled—will be £127 a week, so we are likely to be talking about something substantially less than that, probably if there is a persisting disablement something of the order of 20 or 30 per cent, where you are talking of something around £25 or £30 a week. In a number of instances there will be, in essence, no permanent disablement but the potential to become disabled, and that may well fall below the 14 per cent threshold which applies and means that no payment is made. In terms of numbers, we are trying to get you some numbers. That may sound a bit lame but this is an old and rather small part of the benefits system and it is not on our computer systems, so we are trying to see if we can get you some figures and if we can we will send them to you, but the answer in general terms is that they are likely to be relatively low. As I have already explained, there are considerable restrictions by which people with allergic diseases are covered by the scheme and, of course, they have to meet the particular criteria of prescribed diseases that come within payment at all, so the numbers will be low. In general, numbers of people entering the scheme are staying roughly stable overall. We still have a situation that approaching 40 per cent are due to accidents. We are talking of no more than 10,000 new entrants a year and 40 per cent odd are due to accidents. 60 per cent are due to diseases. Vibration white finger and pneumoconiosis are the largest numbers; allergic diseases are very small numbers. There is no suggestion that there has been any great change in numbers, but that may not reflect the incidence of the disease because it is such a selective group that comes in. If we can get figures, and we have asked for them over the years, we will provide them to you.

  Q70  Lord Broers: Could you give any details of what retraining schemes or other schemes are available to ease reduced earnings for these poor people who are unable to carry on their work?

  Dr Wright: Reduced Earnings Allowance was in fact closed from 30 September 1990 so recipients either received it before that date or, if they are applying now, it is because they had an accident or a disease which started before that date. It is simply a payment towards loss of pay. I stress the word "towards" because it still exists for the reasons I have mentioned, and it was always capped, and in fact the current maximum rate for Reduced Earnings Allowance is £50.84 a week, so it is only a partial contribution. That is not to say that people who have a disability are not helped within the system. One of the things that happened when it was closed was that a parallel provision was made for anybody with a disability, so when Reduced Earnings Allowance was first introduced as a Special Hardship Allowance it only applied within the industrial injuries scheme. Disability Working Allowance, which is now part of the Employment Tax Credit, is available to anybody who has a disability which puts them at a disadvantage in the labour market, so those who cannot receive Reduced Earnings Allowance would have access to the tax credit system to help them. In terms of saying programmes to help people, retraining and so on, that will be attached to Jobcentre Plus through the normal programmes for people who are unemployed or people who have a health condition and are on Incapacity Benefit, and you will be aware that there are proposals to change Incapacity Benefit and the extent and the amount of help that is offered to people on that benefit.

  Q71  Lord Taverne: I want to ask about anaphylactic emergencies in schools. The Anaphylaxis Campaign is setting up a national training programme to educate school nurses on allergies because it feels the Government is not doing enough. What training is there for school nurses, and teachers for that matter, for dealing with such an emergency in a school?

  Mr Wells: If I can take this question in a couple of parts, firstly just to answer it but then also to give you a bit of wider context as to how we would expect health services and educational and social care services to be thinking generally about work strategies that may help the Committee understand what we are about. First, as I am sure the Committee are aware, all school nurses are trained nurses and many are qualified children's nurses, and this means that they will all have had some training and experience in the management of anaphylaxis. It is true to say that many nurses working in schools have access to training courses run by the Anaphylaxis Campaign, which is a well-regarded course, and to a certain extent although the way the question was framed is perfectly reasonable, I do not know that we should have a fear about them having to run a campaign or a course because many such organisations do just that. Lots of people will access courses run by the British Dyslexic Association or the National Autistic Society, so it is quite commonplace in fact for organisations with a particular specialism to design and run courses for the benefit of a whole range of professionals in different services, and that provides them with an income stream, so there is a value in that. In addition, it will be the case that primary care trusts and others will run courses which are relevant for nurses to access as well. It is in fact the case that any nurse who administers an immunisation in a school setting will receive anaphylaxis update training on an annual basis. That is a requirement of their own continuing professional development. School nurses who are involved in the delivery of such immunisations and other access treatments who have a particular knowledge will themselves be engaged in delivering training to school staff. I said I would give you a little bit of background context, if I might. There is a major government programme which is partly in answer to another question that you asked the earlier bodies about inter-departmental collaboration. The Every Child Matters Change for Children programme engages in a whole wide range of departments, and obviously as far as this particular inquiry is concerned the two departments, mine and the Department of Health, are critical. One of the key parts of the programme is to ensure that in every local area there is a Children's Trust and that that Children's Trust owns a children and young people's plan. That plan is basically a commissioning plan, it identifies the key presenting needs in any area, it sets priorities for delivering better services to meet those needs and critically, in relation to my Lord's question, there will be a local workforce strategy agreed by the various partners that are targeting a particular training initiative that is necessary, and indeed they may commission it themselves. The other thing I ought to just mention—and I am not sure if the Committee has got a copy—is we have recently produced some guidance called Managing Medicines in Schools. It is joint guidance from the Department for Health and the Department for Education and Skills. It sets out a framework in effect for ensuring that there is effective practice in schools to support children with a number of allergic conditions, including those who are prone to anaphylaxis, and there is guidance and advice in there as well which is of an information nature.

  Q72  Lord Taverne: Thank you and what is the Department's policy on the use of auto injectors by teachers and students?

  Mr Wells: We would not want those to be used, as it were, just on the teacher's judgment but where there is a child who is prescribed an Epi-pen or some other therapy, and there is an agreement between the parents and the school for a teacher to administer it in the case of anaphylactic shock, and the appropriate training can be delivered to that teacher, then we would support it. In other words, if we just step back again, the guidance I mentioned Managing Medicines has as part of its ambition that where we have children with particular medical needs that there is an individual health care plan, and if that plan identifies that a child carries (or one is held at the school for) an Epipen or adrenaline shot treatment, then there is no reason why the teacher should not deliver it. We would not advocate teachers just holding a stock of those "just in case" because they would not have the judgment, we believe, to decide whether or not the child in front of them is suffering from that shock or some other need.

  Q73  Chairman: In your answer you outlined the training for school nurses and, to a certain extent, for teachers, but I wonder what ongoing audit is there to make sure that they do have appropriate level skills because we all know that you can take people into a training programme but that they have learned to apply those skills is not necessarily the case.

  Mr Wells: No, that is fair comment. The answer to the question though has to be made through local judgment because, to a certain extent, it is rather impossible for a central department to make a judgment as to what is the best way of developing the school's workforce in 33,000 different settings. What we are expecting every school to have are a number of policies, including policies which are related to the support for children with medical conditions, medical health needs, and then to secure appropriate training for their staff on a needs basis. There is a significant amount of money at head teachers' disposal for just that purpose, to ensure that they are developing their school workforce to meet a wider range of demands in addition to teaching and learning, which is obviously their core business. Is does rather depend on the locality.

  Q74  Chairman: Is there a requirement for those skills to be assessed regularly because you could take a school and have people trained, the boxes are ticked, you then have a child who has an anaphylactic reaction, but although the boxes have been ticked the skills are not there at the time?

  Mr Wells: I would certainly agree that the key thing for us is to ensure that there is a depth of understanding of the need and the risk that the school is trying to address. We are very, very keen to ensure that people do not just have tokenistic strategies, tokenistic policies, against which they tick boxes, indeed to that extent we are rather against model policies because they tend to weaken people's engagement in understanding what particular risk they have in their setting and indeed to ensure there is a wider ownership. In fact schools have got a number of statutory duties which we believe are ensuring that school governors and head teachers are taking their responsibilities—basically to address the question as you put it my Lord Chairman—to ensure they have got staff who do have the necessary training. It is a head teacher's responsibility to ask themselves whether the cadre of teachers and support staff they have is capable of delivering across a broad range of issues, not just allergy, if I can say so.

  Q75  Lord May of Oxford: I have a question which, in a sense, is a continuation of this but in the specific context. If another of DfES's good schemes goes well there is one category of an anaphylactic shock which is going to be on the marked increase, I would guess, namely the programme on transforming school food, replacing unhealthy snacks with healthy foods. We all know from the tabloids it is having what we might call "teething problems" with concerned parents turning up to feed their kids junk food through the fence. But supposing it does go well, then the snacks kids eat are more likely to be the sort of thing I have just been eating at the morning break, seeds and nuts, which is one of the major causes of worry in this area. Specifically, against the background of the discussion we have just had in general, to what extent do you see a particular need to really ramp things up a little bit and address very seriously some of the questions which have been asked, not just about ticking boxes of procedure, but making sure people really are on key for this?

  Mr Wells: There are a few things, if I might. First of all, we would expect the parent of the child who has the particular allergy to ensure the school understands that the child has that particular allergy. If I can refer back to one of the answers I gave earlier, that is then the starting point for agreeing an individual healthcare plan for that child.

  Q76  Lord May of Oxford: None of these kids may ever have eaten a nut or a seed.

  Mr Wells: If I can move on, they are going to have eaten one once. If I can at least work on the assumption that the vast majority of parents are likely to become aware of a child's allergy before a school is presented with the reaction to not knowing. The first thing is to make sure the knowledge is shared and the knowledge is understood by a wide group of adults within the school setting so that if they see the incident, if they see the reaction, they can react. The second thing, of course, is to make sure that teachers generally are aware of the likelihood that certain nuts and other foodstuffs can indeed give rise to a shock. I think it is important to recognise, although I respect the question, that nuts are not the only likely cause of anaphylaxis, eggs are, cows' milk can be, fish can be, indeed I heard a reference earlier on to latex, latex can be; you cannot ban everything that could give rise to a shock. What is important is that, first of all, there is a clear understanding that a child is at risk, that the child itself understands it is at risk, and that adults are looking for incidences that could give rise to it. In that sense, we are very clear as a general nature of training and updating teacher's knowledge that must be part of the school's expectation of itself and, indeed, that we are helping schools understand the need for good hygiene generally because in extreme cases, as of course you will know, very allergic children could react to traces of allergens which have just been left on furniture, et cetera. It is a rich question which requires a rich answer, I think, and we are trying to make sure there is a good level of understanding across the piece.

  Q77  Lord Colwyn: It is a question I probably should know the answer to. If a child is given a shot with an epi-pen and, in fact, they are just suffering from a temporary obstruction, apart from an increase in heart rate, does it cause any harm?

  Mr Wells: I am not competent to answer the question. My understanding is in general no, and in general, in any case, back to the answer I gave earlier, even where we do have a child where there is an agreement that the use of an epi-pen is advisable, there is also a requirement that a medical service is called instantly. I think where we are being more careful here is that we do not want to encourage the general use of that treatment amongst untrained folk, and that is after all what teachers are. My understanding is that what I am saying would also apply to, for example, doctor's receptionists. They would not just use it without some prior knowledge of its likely success. In relation to your particular question, I am afraid I do not know the answer to the extent if it could cause harm.

  Chairman: If I might intervene, I think it is dose-related so that if you give an overdose, and that would happen if you used the wrong pen, the wrong dose for a particular child, then you certainly could run into problems, possibly cardiac problems too. They are not things just to be taken lightly.

  Q78  Lord Colwyn: Would a school have supplies of different pens with different doses?

  Mr Wells: No, it is child-specific.

  Q79  Viscount Simon: Again, just going a little bit further, what procedures are currently in place to help students go about their everyday life with allergic diseases in schools and universities?

  Mr Wells: If I can take the university bit first, if you do not mind, because it is a relatively short answer. They are adults and there maybe a number of different services which would help them manage their own conditions. To a certain extent, we would expect the arrangements that would be made within the university to mirror those you would expect to find in the workplace. There is clearly an expectation amongst adults that they would carry their own treatments and they would be aware of their own condition. Nonetheless, universities are large institutions, they will have access to health services, they will want to make sure they are promoting the well-being of their students, and they may very well have their own arrangements. It is not something that we regulate, however, or establish from the centre. As far as schools are concerned, there is a relevance to the answer I just gave. As a child becomes older it becomes an expectation that they will become more able to hold and indeed administer their own treatment and every support should be given to that. We would be looking to school nurses and other health professionals to work with the child, the parent and the school to ensure that as a child is able to take greater control of their own health, they are enabled to do so. That might, for example, mean helping a child know where it can store certain medicines. Some medicines are controlled, as, of course, you will know. My general point comes back to an answer I think I have given twice already, so apologies, that we would expect every school, whether the child is five, 15, 19 or indeed younger than five, every school to have an individual care plan for that child, and there is an agreement updated periodically to make sure that everybody knows how to deal with that case on its own terms. It is quite critical, of course, that the family is involved in these circumstances themselves. It is quite critical to recognise that some parents will encourage a greater level of school involvement in their child's health than others. Indeed, some might be actively resistant to the school being involved in the delivery of the basic treatments et cetera. We have to try and respect all those different shades of opinion against a clear understanding that there is a health and safety requirement on all schools, just as there is in any other public building, and there is a duty in the Education Act to promote well-being.


 
previous page contents next page

House of Lords home page Parliament home page House of Commons home page search page enquiries index

© Parliamentary copyright 2007